Phase I
The stated cause of the suspension of enrollment was the occurrence of two intrathecal catheter-related infections that weren’t related to the drug.
As the coronavirus outbreak that causes COVID-19 escalates, biopharma companies and government agents are working quickly to develop and test a vaccine, although most estimates are it will take 12 to 18 months before it could get to market.
Life sciences companies from across the globe provide updates on their businesses and pipelines.
In addition, the company’s chief scientific officer, Seth Ettenberg, has resigned.
The month of February ended with a flurry of clinical trial announcements. Here’s a look.
Abivax SA announced dosing of the first patient in a U.S. Phase 1/2 clinical trial of ABX196 to treat patients with hepatocellular carcinoma, the most common form of liver cancer..
A federal judge has ruled that a decade’s worth of unpublished clinical trial data from drug companies, universities and other agencies involved, must now be made public.
BioSpace takes a look at some of the investigational products that could, one day, provide relief for migraine sufferers.
Mid-February had a solid number of clinical trial announcements. Here’s a look.
First-time results from recently completed fosciclopirox Phase I safety, dose tolerance, pharmacokinetics and pharmacodynamics trial in advanced solid-tumor patients
PRESS RELEASES